Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 144 Pages
Report ld: 5344814
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Uterine Polyp Forceps Market Size(US$)
CAGR 2025-2031
3.1%
Market Size,2031
USD 19.7
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 16.4 million
Market Forecast in 2031(Value)
US$ 19.7 million
CAGR
3.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Uterine Polyp Forceps market is projected to grow from US$ 15.9 million in 2024 to US$ 19.7 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Uterine polyp forceps is a medical device used in gynecological treatment to remove polyps in the uterus. Uterine polyps are benign tumors located on the surface of the endometrium, usually due to excessive proliferation of endometrial tissue. Although uterine polyps are generally benign, they can cause menstrual abnormalities, infertility, or other gynecological problems, so they often require treatment or removal.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Uterine Polyp Forceps market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- CooperSurgical
- DTR Medical
- Integra LifeSciences
- Vernacare
- Surtex Instruments
- Sklar Corporation
- Bolton Surgical
- BR Surgical
- BD
- Surgical Holdings
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Straight
- Curved
Segment by Application
- Hospitals
- Clinics
CHAPTER OUTLINE
Chapter 1: Defines the Uterine Polyp Forceps study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Uterine Polyp Forceps: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Uterine Polyp Forceps Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Straight
1.2.3 Curved
1.3 Market Segmentation by Application
1.3.1 Global Uterine Polyp Forceps Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Uterine Polyp Forceps Revenue Estimates and Forecasts 2020-2031
2.2 Global Uterine Polyp Forceps Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Uterine Polyp Forceps Sales Estimates and Forecasts 2020-2031
2.4 Global Uterine Polyp Forceps Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Uterine Polyp Forceps Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Uterine Polyp Forceps Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Straight Market Size by Manufacturers
3.5.2 Curved Market Size by Manufacturers
3.6 Global Uterine Polyp Forceps Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Uterine Polyp Forceps Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Uterine Polyp Forceps Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Uterine Polyp Forceps Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Uterine Polyp Forceps Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Uterine Polyp Forceps Sales and Revenue by Type (2020-2031)
6.4 North America Uterine Polyp Forceps Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Uterine Polyp Forceps Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Uterine Polyp Forceps Sales and Revenue by Type (2020-2031)
7.4 Europe Uterine Polyp Forceps Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Uterine Polyp Forceps Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Uterine Polyp Forceps Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Uterine Polyp Forceps Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Uterine Polyp Forceps Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Uterine Polyp Forceps Sales and Revenue by Type (2020-2031)
9.4 Central and South America Uterine Polyp Forceps Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Uterine Polyp Forceps Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Uterine Polyp Forceps Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Uterine Polyp Forceps Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Uterine Polyp Forceps Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 CooperSurgical
11.1.1 CooperSurgical Corporation Information
11.1.2 CooperSurgical Business Overview
11.1.3 CooperSurgical Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.1.4 CooperSurgical Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 CooperSurgical Uterine Polyp Forceps Sales by Product in 2024
11.1.6 CooperSurgical Uterine Polyp Forceps Sales by Application in 2024
11.1.7 CooperSurgical Uterine Polyp Forceps Sales by Geographic Area in 2024
11.1.8 CooperSurgical Uterine Polyp Forceps SWOT Analysis
11.1.9 CooperSurgical Recent Developments
11.2 DTR Medical
11.2.1 DTR Medical Corporation Information
11.2.2 DTR Medical Business Overview
11.2.3 DTR Medical Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.2.4 DTR Medical Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 DTR Medical Uterine Polyp Forceps Sales by Product in 2024
11.2.6 DTR Medical Uterine Polyp Forceps Sales by Application in 2024
11.2.7 DTR Medical Uterine Polyp Forceps Sales by Geographic Area in 2024
11.2.8 DTR Medical Uterine Polyp Forceps SWOT Analysis
11.2.9 DTR Medical Recent Developments
11.3 Integra LifeSciences
11.3.1 Integra LifeSciences Corporation Information
11.3.2 Integra LifeSciences Business Overview
11.3.3 Integra LifeSciences Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.3.4 Integra LifeSciences Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Integra LifeSciences Uterine Polyp Forceps Sales by Product in 2024
11.3.6 Integra LifeSciences Uterine Polyp Forceps Sales by Application in 2024
11.3.7 Integra LifeSciences Uterine Polyp Forceps Sales by Geographic Area in 2024
11.3.8 Integra LifeSciences Uterine Polyp Forceps SWOT Analysis
11.3.9 Integra LifeSciences Recent Developments
11.4 Vernacare
11.4.1 Vernacare Corporation Information
11.4.2 Vernacare Business Overview
11.4.3 Vernacare Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.4.4 Vernacare Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Vernacare Uterine Polyp Forceps Sales by Product in 2024
11.4.6 Vernacare Uterine Polyp Forceps Sales by Application in 2024
11.4.7 Vernacare Uterine Polyp Forceps Sales by Geographic Area in 2024
11.4.8 Vernacare Uterine Polyp Forceps SWOT Analysis
11.4.9 Vernacare Recent Developments
11.5 Surtex Instruments
11.5.1 Surtex Instruments Corporation Information
11.5.2 Surtex Instruments Business Overview
11.5.3 Surtex Instruments Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.5.4 Surtex Instruments Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Surtex Instruments Uterine Polyp Forceps Sales by Product in 2024
11.5.6 Surtex Instruments Uterine Polyp Forceps Sales by Application in 2024
11.5.7 Surtex Instruments Uterine Polyp Forceps Sales by Geographic Area in 2024
11.5.8 Surtex Instruments Uterine Polyp Forceps SWOT Analysis
11.5.9 Surtex Instruments Recent Developments
11.6 Sklar Corporation
11.6.1 Sklar Corporation Corporation Information
11.6.2 Sklar Corporation Business Overview
11.6.3 Sklar Corporation Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.6.4 Sklar Corporation Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sklar Corporation Recent Developments
11.7 Bolton Surgical
11.7.1 Bolton Surgical Corporation Information
11.7.2 Bolton Surgical Business Overview
11.7.3 Bolton Surgical Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.7.4 Bolton Surgical Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bolton Surgical Recent Developments
11.8 BR Surgical
11.8.1 BR Surgical Corporation Information
11.8.2 BR Surgical Business Overview
11.8.3 BR Surgical Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.8.4 BR Surgical Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 BR Surgical Recent Developments
11.9 BD
11.9.1 BD Corporation Information
11.9.2 BD Business Overview
11.9.3 BD Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.9.4 BD Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 BD Recent Developments
11.10 Surgical Holdings
11.10.1 Surgical Holdings Corporation Information
11.10.2 Surgical Holdings Business Overview
11.10.3 Surgical Holdings Uterine Polyp Forceps Product Models, Descriptions and Specifications
11.10.4 Surgical Holdings Uterine Polyp Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Surgical Holdings Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Uterine Polyp Forceps Industry Chain
12.2 Uterine Polyp Forceps Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Uterine Polyp Forceps Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Uterine Polyp Forceps Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Uterine Polyp Forceps Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Uterine Polyp Forceps Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Uterine Polyp Forceps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Uterine Polyp Forceps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Uterine Polyp Forceps Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Uterine Polyp Forceps Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Uterine Polyp Forceps Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Uterine Polyp Forceps Sales by Region (2020-2025) & (K Units)
Table 8. Global Uterine Polyp Forceps Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Uterine Polyp Forceps Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Uterine Polyp Forceps Sales Share by Manufacturers (2020-2025)
Table 12. Global Uterine Polyp Forceps Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Uterine Polyp Forceps Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Uterine Polyp Forceps by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Polyp Forceps as of 2024)
Table 16. Global Uterine Polyp Forceps Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Uterine Polyp Forceps Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Uterine Polyp Forceps Manufacturing Base and Headquarters
Table 19. Global Uterine Polyp Forceps Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Uterine Polyp Forceps Sales by Type (2020-2025) & (K Units)
Table 23. Global Uterine Polyp Forceps Sales by Type (2026-2031) & (K Units)
Table 24. Global Uterine Polyp Forceps Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Uterine Polyp Forceps Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Uterine Polyp Forceps ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Uterine Polyp Forceps Sales by Application (2020-2025) & (K Units)
Table 29. Global Uterine Polyp Forceps Sales by Application (2026-2031) & (K Units)
Table 30. Uterine Polyp Forceps High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Uterine Polyp Forceps Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Uterine Polyp Forceps Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Uterine Polyp Forceps ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Uterine Polyp Forceps Growth Accelerators and Market Barriers
Table 37. North America Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Uterine Polyp Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Uterine Polyp Forceps Growth Accelerators and Market Barriers
Table 40. Europe Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Uterine Polyp Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Uterine Polyp Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Uterine Polyp Forceps Growth Accelerators and Market Barriers
Table 45. Southeast Asia Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Uterine Polyp Forceps Investment Opportunities and Key Challenges
Table 47. Central and South America Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Uterine Polyp Forceps Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Uterine Polyp Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. CooperSurgical Corporation Information
Table 51. CooperSurgical Description and Major Businesses
Table 52. CooperSurgical Product Models, Descriptions and Specifications
Table 53. CooperSurgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. CooperSurgical Sales Value Proportion by Product in 2024
Table 55. CooperSurgical Sales Value Proportion by Application in 2024
Table 56. CooperSurgical Sales Value Proportion by Geographic Area in 2024
Table 57. CooperSurgical Uterine Polyp Forceps SWOT Analysis
Table 58. CooperSurgical Recent Developments
Table 59. DTR Medical Corporation Information
Table 60. DTR Medical Description and Major Businesses
Table 61. DTR Medical Product Models, Descriptions and Specifications
Table 62. DTR Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. DTR Medical Sales Value Proportion by Product in 2024
Table 64. DTR Medical Sales Value Proportion by Application in 2024
Table 65. DTR Medical Sales Value Proportion by Geographic Area in 2024
Table 66. DTR Medical Uterine Polyp Forceps SWOT Analysis
Table 67. DTR Medical Recent Developments
Table 68. Integra LifeSciences Corporation Information
Table 69. Integra LifeSciences Description and Major Businesses
Table 70. Integra LifeSciences Product Models, Descriptions and Specifications
Table 71. Integra LifeSciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Integra LifeSciences Sales Value Proportion by Product in 2024
Table 73. Integra LifeSciences Sales Value Proportion by Application in 2024
Table 74. Integra LifeSciences Sales Value Proportion by Geographic Area in 2024
Table 75. Integra LifeSciences Uterine Polyp Forceps SWOT Analysis
Table 76. Integra LifeSciences Recent Developments
Table 77. Vernacare Corporation Information
Table 78. Vernacare Description and Major Businesses
Table 79. Vernacare Product Models, Descriptions and Specifications
Table 80. Vernacare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vernacare Sales Value Proportion by Product in 2024
Table 82. Vernacare Sales Value Proportion by Application in 2024
Table 83. Vernacare Sales Value Proportion by Geographic Area in 2024
Table 84. Vernacare Uterine Polyp Forceps SWOT Analysis
Table 85. Vernacare Recent Developments
Table 86. Surtex Instruments Corporation Information
Table 87. Surtex Instruments Description and Major Businesses
Table 88. Surtex Instruments Product Models, Descriptions and Specifications
Table 89. Surtex Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Surtex Instruments Sales Value Proportion by Product in 2024
Table 91. Surtex Instruments Sales Value Proportion by Application in 2024
Table 92. Surtex Instruments Sales Value Proportion by Geographic Area in 2024
Table 93. Surtex Instruments Uterine Polyp Forceps SWOT Analysis
Table 94. Surtex Instruments Recent Developments
Table 95. Sklar Corporation Corporation Information
Table 96. Sklar Corporation Description and Major Businesses
Table 97. Sklar Corporation Product Models, Descriptions and Specifications
Table 98. Sklar Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sklar Corporation Recent Developments
Table 100. Bolton Surgical Corporation Information
Table 101. Bolton Surgical Description and Major Businesses
Table 102. Bolton Surgical Product Models, Descriptions and Specifications
Table 103. Bolton Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Bolton Surgical Recent Developments
Table 105. BR Surgical Corporation Information
Table 106. BR Surgical Description and Major Businesses
Table 107. BR Surgical Product Models, Descriptions and Specifications
Table 108. BR Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. BR Surgical Recent Developments
Table 110. BD Corporation Information
Table 111. BD Description and Major Businesses
Table 112. BD Product Models, Descriptions and Specifications
Table 113. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. BD Recent Developments
Table 115. Surgical Holdings Corporation Information
Table 116. Surgical Holdings Description and Major Businesses
Table 117. Surgical Holdings Product Models, Descriptions and Specifications
Table 118. Surgical Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Surgical Holdings Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Uterine Polyp Forceps Product Picture
Figure 2. Global Uterine Polyp Forceps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Straight Product Picture
Figure 4. Curved Product Picture
Figure 5. Global Uterine Polyp Forceps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Uterine Polyp Forceps Report Years Considered
Figure 9. Global Uterine Polyp Forceps Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 11. Global Uterine Polyp Forceps Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Uterine Polyp Forceps Revenue Market Share by Region (2020-2031)
Figure 13. Global Uterine Polyp Forceps Sales (2020-2031) & (K Units)
Figure 14. Global Uterine Polyp Forceps Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Uterine Polyp Forceps Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Uterine Polyp Forceps Sales Volume Market Share in 2024
Figure 17. Global Uterine Polyp Forceps Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Straight Revenue Market Share by Manufacturer in 2024
Figure 20. Curved Revenue Market Share by Manufacturer in 2024
Figure 21. Global Uterine Polyp Forceps Sales Market Share by Type (2020-2031)
Figure 22. Global Uterine Polyp Forceps Revenue Market Share by Type (2020-2031)
Figure 23. Global Uterine Polyp Forceps Sales Market Share by Application (2020-2031)
Figure 24. Global Uterine Polyp Forceps Revenue Market Share by Application (2020-2031)
Figure 25. North America Uterine Polyp Forceps Sales YoY (2020-2031) & (K Units)
Figure 26. North America Uterine Polyp Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Uterine Polyp Forceps Sales Revenue (US$ Million) in 2024
Figure 28. North America Uterine Polyp Forceps Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Uterine Polyp Forceps Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Uterine Polyp Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Uterine Polyp Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Uterine Polyp Forceps Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Uterine Polyp Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Uterine Polyp Forceps Sales Revenue (US$ Million) in 2024
Figure 38. Europe Uterine Polyp Forceps Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Uterine Polyp Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Uterine Polyp Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Uterine Polyp Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 43. France Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Uterine Polyp Forceps Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Uterine Polyp Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Uterine Polyp Forceps Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Uterine Polyp Forceps Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Uterine Polyp Forceps Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Uterine Polyp Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Uterine Polyp Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 58. India Uterine Polyp Forceps Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Uterine Polyp Forceps Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Uterine Polyp Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Uterine Polyp Forceps Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Uterine Polyp Forceps Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Uterine Polyp Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Uterine Polyp Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Uterine Polyp Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Uterine Polyp Forceps Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Uterine Polyp Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Uterine Polyp Forceps Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Uterine Polyp Forceps Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Uterine Polyp Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Uterine Polyp Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Uterine Polyp Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Uterine Polyp Forceps Revenue (2020-2025) & (US$ Million)
Figure 79. Uterine Polyp Forceps Industry Chain Mapping
Figure 80. Regional Uterine Polyp Forceps Manufacturing Base Distribution (%)
Figure 81. Global Uterine Polyp Forceps Production Market Share by Region (2020-2031)
Figure 82. Uterine Polyp Forceps Production Process
Figure 83. Regional Uterine Polyp Forceps Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Uterine Polyp Forceps market?
What was the global market size of Uterine Polyp Forceps in 2025?
What is the annual compound growth rate of the global Uterine Polyp Forceps market size from 2025 to 2031?
What was the global market size of Uterine Polyp Forceps in 2031?
Related Reports
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2026
The global Uterine Polyp Forceps market was valued at US$ 16.38 million in 2025 and is anticipated to reach US$ 20.22 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 116
USD 2900.00
(Single User License)
Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 81
USD 2900.00
(Single User License)
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Uterine Polyp Forceps was estimated to be worth US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 102
USD 3950.00
(Single User License)
Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-10
Pages: 123
USD 3950.00
(Single User License)
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
USD 3950.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2026
The global Uterine Polyp Forceps market was valued at US$ 16.38 million in 2025 and is anticipated to reach US$ 20.22 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 116
USD 2900.00 (Single User License)Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 81
USD 2900.00 (Single User License)Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Uterine Polyp Forceps was estimated to be worth US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 102
USD 3950.00 (Single User License)Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-04-12
Pages: 105
USD 4900.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-10
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now